Reports

Industry Research Reports

Global Targeted Genome Analysis Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Targeted Genome Analysis Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-08-05

Pages: 132 Pages

Report ld: 4861052

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Targeted Genome Analysis Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Targeted Genome Analysis Kits are specialized tools used in molecular biology and genetics to analyze specific regions of the genome. These kits allow researchers to focus on particular genes, mutations, or sequences of interest, rather than sequencing the entire genome. They are commonly used for studying genetic diseases, cancer mutations, and specific biomarkers.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Targeted Genome Analysis Kits leading manufacturers including Agena Bioscience, BD, Thermo Fisher Scientific, Illumina, BGI, Agilent, Daicel Arbor Biosciences, Singleron, Mole Bioscience, etc., dominate supply; the top five capture approximately % of global revenue, with Agena Bioscience leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Targeted Genome Analysis Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Agena Bioscience
  • BD
  • Thermo Fisher Scientific
  • Illumina
  • BGI
  • Agilent
  • Daicel Arbor Biosciences
  • Singleron
  • Mole Bioscience

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • PCR-based Targeted Kits
  • NGS (Next Generation Sequencing)-based Targeted Kits
  • Other

Segment by Application

  • Hospital
  • Laboratory
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Targeted Genome Analysis Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Targeted Genome Analysis Kits: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Targeted Genome Analysis Kits Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 PCR-based Targeted Kits

1.2.3 NGS (Next Generation Sequencing)-based Targeted Kits

1.2.4 Other

1.3 Market Segmentation by Application

1.3.1 Global Targeted Genome Analysis Kits Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Laboratory

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Targeted Genome Analysis Kits Revenue Estimates and Forecasts 2020-2031

2.2 Global Targeted Genome Analysis Kits Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Targeted Genome Analysis Kits Sales Estimates and Forecasts 2020-2031

2.4 Global Targeted Genome Analysis Kits Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Competition by Manufacturers

3.1 Global Targeted Genome Analysis Kits Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Targeted Genome Analysis Kits Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 PCR-based Targeted Kits Market Size by Manufacturers

3.5.2 NGS (Next Generation Sequencing)-based Targeted Kits Market Size by Manufacturers

3.5.3 Other Market Size by Manufacturers

3.6 Global Targeted Genome Analysis Kits Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global Targeted Genome Analysis Kits Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Targeted Genome Analysis Kits Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global Targeted Genome Analysis Kits Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Targeted Genome Analysis Kits Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

muLu

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Targeted Genome Analysis Kits Sales and Revenue by Type (2020-2031)

6.4 North America Targeted Genome Analysis Kits Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Targeted Genome Analysis Kits Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

muLu

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Targeted Genome Analysis Kits Sales and Revenue by Type (2020-2031)

7.4 Europe Targeted Genome Analysis Kits Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Targeted Genome Analysis Kits Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Targeted Genome Analysis Kits Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Targeted Genome Analysis Kits Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Targeted Genome Analysis Kits Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

muLu

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Targeted Genome Analysis Kits Sales and Revenue by Type (2020-2031)

9.4 Central and South America Targeted Genome Analysis Kits Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Targeted Genome Analysis Kits Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Targeted Genome Analysis Kits Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Targeted Genome Analysis Kits Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Targeted Genome Analysis Kits Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Agena Bioscience

11.1.1 Agena Bioscience Corporation Information

11.1.2 Agena Bioscience Business Overview

11.1.3 Agena Bioscience Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.1.4 Agena Bioscience Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Agena Bioscience Targeted Genome Analysis Kits Sales by Product in 2024

11.1.6 Agena Bioscience Targeted Genome Analysis Kits Sales by Application in 2024

11.1.7 Agena Bioscience Targeted Genome Analysis Kits Sales by Geographic Area in 2024

11.1.8 Agena Bioscience Targeted Genome Analysis Kits SWOT Analysis

11.1.9 Agena Bioscience Recent Developments

11.2 BD

11.2.1 BD Corporation Information

11.2.2 BD Business Overview

11.2.3 BD Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.2.4 BD Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 BD Targeted Genome Analysis Kits Sales by Product in 2024

11.2.6 BD Targeted Genome Analysis Kits Sales by Application in 2024

11.2.7 BD Targeted Genome Analysis Kits Sales by Geographic Area in 2024

11.2.8 BD Targeted Genome Analysis Kits SWOT Analysis

11.2.9 BD Recent Developments

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Corporation Information

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.3.4 Thermo Fisher Scientific Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Thermo Fisher Scientific Targeted Genome Analysis Kits Sales by Product in 2024

11.3.6 Thermo Fisher Scientific Targeted Genome Analysis Kits Sales by Application in 2024

11.3.7 Thermo Fisher Scientific Targeted Genome Analysis Kits Sales by Geographic Area in 2024

11.3.8 Thermo Fisher Scientific Targeted Genome Analysis Kits SWOT Analysis

11.3.9 Thermo Fisher Scientific Recent Developments

11.4 Illumina

11.4.1 Illumina Corporation Information

11.4.2 Illumina Business Overview

11.4.3 Illumina Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.4.4 Illumina Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Illumina Targeted Genome Analysis Kits Sales by Product in 2024

11.4.6 Illumina Targeted Genome Analysis Kits Sales by Application in 2024

11.4.7 Illumina Targeted Genome Analysis Kits Sales by Geographic Area in 2024

11.4.8 Illumina Targeted Genome Analysis Kits SWOT Analysis

11.4.9 Illumina Recent Developments

11.5 BGI

11.5.1 BGI Corporation Information

11.5.2 BGI Business Overview

11.5.3 BGI Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.5.4 BGI Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 BGI Targeted Genome Analysis Kits Sales by Product in 2024

11.5.6 BGI Targeted Genome Analysis Kits Sales by Application in 2024

11.5.7 BGI Targeted Genome Analysis Kits Sales by Geographic Area in 2024

11.5.8 BGI Targeted Genome Analysis Kits SWOT Analysis

11.5.9 BGI Recent Developments

11.6 Agilent

11.6.1 Agilent Corporation Information

11.6.2 Agilent Business Overview

11.6.3 Agilent Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.6.4 Agilent Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Agilent Recent Developments

11.7 Daicel Arbor Biosciences

11.7.1 Daicel Arbor Biosciences Corporation Information

11.7.2 Daicel Arbor Biosciences Business Overview

11.7.3 Daicel Arbor Biosciences Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.7.4 Daicel Arbor Biosciences Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Daicel Arbor Biosciences Recent Developments

11.8 Singleron

11.8.1 Singleron Corporation Information

11.8.2 Singleron Business Overview

11.8.3 Singleron Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.8.4 Singleron Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Singleron Recent Developments

11.9 Mole Bioscience

11.9.1 Mole Bioscience Corporation Information

11.9.2 Mole Bioscience Business Overview

11.9.3 Mole Bioscience Targeted Genome Analysis Kits Product Models, Descriptions and Specifications

11.9.4 Mole Bioscience Targeted Genome Analysis Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Mole Bioscience Recent Developments

muLu

12 Value Chain and Supply-Chain Analysis

12.1 Targeted Genome Analysis Kits Industry Chain

12.2 Targeted Genome Analysis Kits Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Targeted Genome Analysis Kits Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Targeted Genome Analysis Kits Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Targeted Genome Analysis Kits Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global Targeted Genome Analysis Kits Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Targeted Genome Analysis Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Targeted Genome Analysis Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Targeted Genome Analysis Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Targeted Genome Analysis Kits Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Targeted Genome Analysis Kits Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Targeted Genome Analysis Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Targeted Genome Analysis Kits Sales by Region (2020-2025) & (K Units)
Table 8. Global Targeted Genome Analysis Kits Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Targeted Genome Analysis Kits Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Targeted Genome Analysis Kits Sales Share by Manufacturers (2020-2025)
Table 12. Global Targeted Genome Analysis Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Targeted Genome Analysis Kits Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Targeted Genome Analysis Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Genome Analysis Kits as of 2024)
Table 16. Global Targeted Genome Analysis Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Targeted Genome Analysis Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Targeted Genome Analysis Kits Manufacturing Base and Headquarters
Table 19. Global Targeted Genome Analysis Kits Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Targeted Genome Analysis Kits Sales by Type (2020-2025) & (K Units)
Table 23. Global Targeted Genome Analysis Kits Sales by Type (2026-2031) & (K Units)
Table 24. Global Targeted Genome Analysis Kits Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Targeted Genome Analysis Kits Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Targeted Genome Analysis Kits ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Targeted Genome Analysis Kits Sales by Application (2020-2025) & (K Units)
Table 29. Global Targeted Genome Analysis Kits Sales by Application (2026-2031) & (K Units)
Table 30. Targeted Genome Analysis Kits High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Targeted Genome Analysis Kits Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Targeted Genome Analysis Kits Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Targeted Genome Analysis Kits ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Targeted Genome Analysis Kits Growth Accelerators and Market Barriers
Table 37. North America Targeted Genome Analysis Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Targeted Genome Analysis Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Targeted Genome Analysis Kits Growth Accelerators and Market Barriers
Table 40. Europe Targeted Genome Analysis Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Targeted Genome Analysis Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Targeted Genome Analysis Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Targeted Genome Analysis Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Targeted Genome Analysis Kits Growth Accelerators and Market Barriers
Table 45. Southeast Asia Targeted Genome Analysis Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Targeted Genome Analysis Kits Investment Opportunities and Key Challenges
Table 47. Central and South America Targeted Genome Analysis Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Targeted Genome Analysis Kits Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Targeted Genome Analysis Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Agena Bioscience Corporation Information
Table 51. Agena Bioscience Description and Major Businesses
Table 52. Agena Bioscience Product Models, Descriptions and Specifications
Table 53. Agena Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Agena Bioscience Sales Value Proportion by Product in 2024
Table 55. Agena Bioscience Sales Value Proportion by Application in 2024
Table 56. Agena Bioscience Sales Value Proportion by Geographic Area in 2024
Table 57. Agena Bioscience Targeted Genome Analysis Kits SWOT Analysis
Table 58. Agena Bioscience Recent Developments
Table 59. BD Corporation Information
Table 60. BD Description and Major Businesses
Table 61. BD Product Models, Descriptions and Specifications
Table 62. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. BD Sales Value Proportion by Product in 2024
Table 64. BD Sales Value Proportion by Application in 2024
Table 65. BD Sales Value Proportion by Geographic Area in 2024
Table 66. BD Targeted Genome Analysis Kits SWOT Analysis
Table 67. BD Recent Developments
Table 68. Thermo Fisher Scientific Corporation Information
Table 69. Thermo Fisher Scientific Description and Major Businesses
Table 70. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 71. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 73. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 74. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 75. Thermo Fisher Scientific Targeted Genome Analysis Kits SWOT Analysis
Table 76. Thermo Fisher Scientific Recent Developments
Table 77. Illumina Corporation Information
Table 78. Illumina Description and Major Businesses
Table 79. Illumina Product Models, Descriptions and Specifications
Table 80. Illumina Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Illumina Sales Value Proportion by Product in 2024
Table 82. Illumina Sales Value Proportion by Application in 2024
Table 83. Illumina Sales Value Proportion by Geographic Area in 2024
Table 84. Illumina Targeted Genome Analysis Kits SWOT Analysis
Table 85. Illumina Recent Developments
Table 86. BGI Corporation Information
Table 87. BGI Description and Major Businesses
Table 88. BGI Product Models, Descriptions and Specifications
Table 89. BGI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BGI Sales Value Proportion by Product in 2024
Table 91. BGI Sales Value Proportion by Application in 2024
Table 92. BGI Sales Value Proportion by Geographic Area in 2024
Table 93. BGI Targeted Genome Analysis Kits SWOT Analysis
Table 94. BGI Recent Developments
Table 95. Agilent Corporation Information
Table 96. Agilent Description and Major Businesses
Table 97. Agilent Product Models, Descriptions and Specifications
Table 98. Agilent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Agilent Recent Developments
Table 100. Daicel Arbor Biosciences Corporation Information
Table 101. Daicel Arbor Biosciences Description and Major Businesses
Table 102. Daicel Arbor Biosciences Product Models, Descriptions and Specifications
Table 103. Daicel Arbor Biosciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Daicel Arbor Biosciences Recent Developments
Table 105. Singleron Corporation Information
Table 106. Singleron Description and Major Businesses
Table 107. Singleron Product Models, Descriptions and Specifications
Table 108. Singleron Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Singleron Recent Developments
Table 110. Mole Bioscience Corporation Information
Table 111. Mole Bioscience Description and Major Businesses
Table 112. Mole Bioscience Product Models, Descriptions and Specifications
Table 113. Mole Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Mole Bioscience Recent Developments
Table 115. Key Raw Materials Distribution
Table 116. Raw Materials Key Suppliers
Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 118. Milestones in Production Technology Evolution
Table 119. Distributors List
Table 120. Market Trends and Market Evolution
Table 121. Market Drivers and Opportunities
Table 122. Market Challenges, Risks, and Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Targeted Genome Analysis Kits Product Picture
Figure 2. Global Targeted Genome Analysis Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. PCR-based Targeted Kits Product Picture
Figure 4. NGS (Next Generation Sequencing)-based Targeted Kits Product Picture
Figure 5. Other Product Picture
Figure 6. Global Targeted Genome Analysis Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Laboratory
Figure 9. Other
Figure 10. Targeted Genome Analysis Kits Report Years Considered
Figure 11. Global Targeted Genome Analysis Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 13. Global Targeted Genome Analysis Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Targeted Genome Analysis Kits Revenue Market Share by Region (2020-2031)
Figure 15. Global Targeted Genome Analysis Kits Sales (2020-2031) & (K Units)
Figure 16. Global Targeted Genome Analysis Kits Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Targeted Genome Analysis Kits Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Targeted Genome Analysis Kits Sales Volume Market Share in 2024
Figure 19. Global Targeted Genome Analysis Kits Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. PCR-based Targeted Kits Revenue Market Share by Manufacturer in 2024
Figure 22. NGS (Next Generation Sequencing)-based Targeted Kits Revenue Market Share by Manufacturer in 2024
Figure 23. Other Revenue Market Share by Manufacturer in 2024
Figure 24. Global Targeted Genome Analysis Kits Sales Market Share by Type (2020-2031)
Figure 25. Global Targeted Genome Analysis Kits Revenue Market Share by Type (2020-2031)
Figure 26. Global Targeted Genome Analysis Kits Sales Market Share by Application (2020-2031)
Figure 27. Global Targeted Genome Analysis Kits Revenue Market Share by Application (2020-2031)
Figure 28. North America Targeted Genome Analysis Kits Sales YoY (2020-2031) & (K Units)
Figure 29. North America Targeted Genome Analysis Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Targeted Genome Analysis Kits Sales Revenue (US$ Million) in 2024
Figure 31. North America Targeted Genome Analysis Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Targeted Genome Analysis Kits Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Targeted Genome Analysis Kits Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Targeted Genome Analysis Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Targeted Genome Analysis Kits Sales Revenue (US$ Million) in 2024
Figure 41. Europe Targeted Genome Analysis Kits Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Targeted Genome Analysis Kits Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 46. France Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Targeted Genome Analysis Kits Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Targeted Genome Analysis Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Targeted Genome Analysis Kits Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Targeted Genome Analysis Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Targeted Genome Analysis Kits Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 61. India Targeted Genome Analysis Kits Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Targeted Genome Analysis Kits Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Targeted Genome Analysis Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Targeted Genome Analysis Kits Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Targeted Genome Analysis Kits Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Targeted Genome Analysis Kits Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Targeted Genome Analysis Kits Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Targeted Genome Analysis Kits Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Targeted Genome Analysis Kits Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Targeted Genome Analysis Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Targeted Genome Analysis Kits Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Targeted Genome Analysis Kits Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Targeted Genome Analysis Kits Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Targeted Genome Analysis Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Targeted Genome Analysis Kits Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Targeted Genome Analysis Kits Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Targeted Genome Analysis Kits Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Targeted Genome Analysis Kits Revenue (2020-2025) & (US$ Million)
Figure 82. Targeted Genome Analysis Kits Industry Chain Mapping
Figure 83. Regional Targeted Genome Analysis Kits Manufacturing Base Distribution (%)
Figure 84. Global Targeted Genome Analysis Kits Production Market Share by Region (2020-2031)
Figure 85. Targeted Genome Analysis Kits Production Process
Figure 86. Regional Targeted Genome Analysis Kits Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Targeted Genome Analysis Kits market?zhanKai
The top companies in the global Targeted Genome Analysis Kits market are Agena Bioscience、BD、Thermo Fisher Scientific.
den_biaoTiZhungShi

Related Reports

Global Targeted Genome Analysis Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-08-05

Pages: 132 Pages

Report ld: 4861052

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now